shandong fangming pharmaceutical co., ltd
Keywords : raw drug materials
Description : Shandong Fangming Pharmaceutical Co., Ltd is a key combination medicine manufacturing enterprising in produce Western medicine and raw material.The registered capital of the enterprise is 106million yuan RMB, the total assets is 260 million yuan RMB. The existing 120 scientists, of whom 14 were senior engineer, licensed pharmacist 12, 94 mid-level technicians. There are Marketing Company, Product Research and Development Center, The Department of Quality Assurance, eight Workshops etc. In March of 2002, Fangming was certified by GMP for all the workshops (tablets, capsule, injection, gel, cream and API).
API Glucurolactone, Etamsylate, Brominsoval, had exported to the United States, India, Ukraine, Russia, Germany, Switzerland, Taiwan. The amount of exports is 1500, 000 U.S. dollars every year. In 2003, Fangming was appraised "AAA credit pharmaceutical industry enterprises” by the Chinese credit assessment centers. In 2004, Fangming was certified “the high-tech enterprise” by department of science and technology of Shandong province.
We have a standardized management and control standards, product quality is stable At present, with an annual output of small capacity injection 1 billion, 2billion tablets, capsules 1.2 billion, 0.8 billion ointment, the API 1800 tons, of which Injection is the small capacity of the domestic production capacity of the largest businesses.
In 2008, the company to achieve industrial output value 1.6 billion yuan, sales income 1.5 billion yuan, profits and taxes 100 million yuan, in 2009 plans to complete the industrial production value of 2.4 billion yuan, sales income of 2.2 billion yuan, tens of millions of super-profits and taxes. |
